8
Jun 23
Agilent Independent Global Lab Sustainability Survey Sheds Light on Progress Towards Greener Labs
Agilent Independent Global Lab Sustainability Survey Sheds Light on Progress Towards Greener Labs Agilent Technologies Inc. (NYSE: A) today announced...
Read More
30
May 23
Agilent BioTek Celebrates a Decade of Cell Imaging and Microscopy Innovation
Agilent BioTek Celebrates a Decade of Cell Imaging and Microscopy Innovation Agilent Technologies Inc. (NYSE: A) announces the 10th anniversary...
Read More
16
May 23
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals
Agilent Wins SEAL Award for Innovative Products that Help Customers Achieve Their Sustainability Goals Agilent Technologies Inc. (NYSE: A) today...
Read More
4
May 23
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye
Agilent Announces Solutions Innovation Research Award to Dr. Jiangbin Ye Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin...
Read More
10
Mar 23
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023
Agilent Announces End-to-End Digital Pathology Workflow Solution at USCAP 2023 Agilent Technologies Inc. (NYSE: A) announced today a highly anticipated...
Read More
16
Oct 22
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market
Telix Partnership Expands GE Healthcare Immuno-Diagnostics Offering to the Global Clinical Research Market Melbourne (Australia) – 17 October 2022. Telix...
Read More
19
Jul 22
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award
Agilent’s Certified Pre-Owned Instruments Program Receives Environmental Award Agilent Technologies Inc. (NYSE: A) today announced the company’s Certified Pre-Owned Instruments...
Read More
5
Apr 22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Esophageal Squamous Cell Carcinoma Agilent Technologies Inc....
Read More
5
Apr 22
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC)
Agilent Companion Diagnostic Expands CE-IVD Mark for PD-L1 IHC 28-8 pharmDx to Include Muscle-Invasive Urothelial Carcinoma (MIUC) Agilent Technologies Inc....
Read More
7
Jan 22
The Innovators 2021
The Innovators 2021 R-TRACKER: A TRUE MILESTONE IN SPECIMEN TRACEABILITY Traceability is of paramount importance for patient safety...
Read More
